Effects of atorvastatin and rosuvastatin on renal function in patients with type 2 diabetes mellitus

American Journal of Cardiology

Volumn 115, Issue 5, 2015, Pages 619-624

  Lai, Chao Lun ^a,b,c   Chou, Hsu Wen ^c   Chan, K Arnold ^a,c   Lai, Mei Shu ^a,c  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALLOPURINOL; AMINOGLYCOSIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; ATORVASTATIN; CEPHALOSPORIN DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HISTAMINE H1 RECEPTOR ANTAGONIST; LOOP DIURETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PENICILLIN DERIVATIVE; PROTON PUMP INHIBITOR; QUINOLONE DERIVATIVE; ROSUVASTATIN; SULFONAMIDE; THIAZIDE DIURETIC AGENT; FLUOROBENZENE; HEPTANOIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PYRIMIDINE DERIVATIVE; PYRROLE DERIVATIVE;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA BASE; DIABETIC PATIENT; DRUG EFFICACY; DRUG SAFETY; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEALTH CARE; HEALTH PROGRAM; HUMAN; KIDNEY FUNCTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NATIONAL HEALTH INSURANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TAIWAN; TREATMENT DURATION; TREATMENT OUTCOME; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; COMPLICATION; DRUG EFFECTS; ETHNOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; DIABETES MELLITUS, TYPE 2; FEMALE; FLUOROBENZENES; GLOMERULAR FILTRATION RATE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PYRIMIDINES; PYRROLES; RETROSPECTIVE STUDIES; SULFONAMIDES; TAIWAN;

EID: 84923047363     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2014.12.009     Document Type: Article

References (22)

1. R.G. Fassett, I.K. Robertson, M.J. Ball, D.P. Geraghty, and J.S. Coombes Effect of atorvastatin on kidney function in chronic kidney disease: a randomised double-blind placebo-controlled trial Atherosclerosis 213 2010 218 224
2. S. Bangalore, R. Fayyad, G.K. Hovingh, R. Laskey, L. Vogt, D.A. DeMicco, D.D. Waters Treating to New Targets Steering Committee and Investigators Statin and the risk of renal-related serious adverse events: analysis from the IDEAL, TNT, CARDS, ASPEN, SPARCL, and other placebo-controlled trials Am J Cardiol 113 2014 2018 2020
3. S.C. Palmer, S.D. Navaneethan, J. Craig, D.W. Johnson, V. Perkovic, J. Hegbrant, and G.F. Strippoli HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis Cochrane Database Syst Rev 5 2014 CD007784
4. G. Savarese, F. Musella, M. Volpe, F. Paneni, and P. Perrone-Filardi Effects of atorvastatin and rosuvastatin on renal function: a meta-analysis Int J Cardiol 167 2013 2482 2489
5. H. Takagi, and T. Umemoto A meta-analysis of randomized trials for effects of atorvastatin on renal function in chronic kidney disease Int J Cardiol 152 2011 242 244
6. Y. Wu, Y. Wang, C. An, Z. Dong, H. Liu, Y. Zhang, M. Zhang, and F. An Effects of rosuvastatin and atorvastatin on renal function: meta-analysis Circ J 76 2012 1259 1266
7. V.G. Athyros, D.P. Mikhailidis, A.A. Papageorgiou, A.N. Symeonidis, A.N. Pehlivanidis, V.I. Bouloukos, and M. Elisaf The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) study J Clin Pathol 57 2004 728 734
8. R. Collins, J. Armitage, S. Parish, P. Sleigh, R. Peto Heart Protection Study Collaborative Group MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial Lancet 361 2003 2005 2016
9. S. Sandhu, N. Wiebe, L.F. Fried, and M. Tonelli Statins for improving renal outcomes: a meta-analysis J Am Soc Nephrol 17 2006 2006 2016
10. G. Corrao, D. Soranna, M. Casula, L. Merlino, M.G. Porcellini, and A.L. Catapano High-potency statins increase the risk of acute kidney injury: evidence from a large population-based study Atherosclerosis 234 2014 224 229
11. C.R. Dormuth, B.R. Hemmelgarn, J.M. Paterson, M.T. James, G.F. Teare, C.B. Raymond, J.P. Lafrance, A. Levy, A.X. Garg, P. Ernst Canadian Network for Observational Drug Effect Studies (CNODES) Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases BMJ 346 2013 f880
12. Y.H. Chung, Y.C. Lee, C.H. Chang, M.S. Lin, J.W. Lin, and M.S. Lai Statins of high versus low cholesterol-lowering efficacy and the development of severe renal failure Pharmacoepidemiol Drug Saf 22 2013 583 592
13. T.T. Lee, S.H. Cheng, C.C. Chen, and M.S. Lai A pay-for-performance program for diabetes care in Taiwan: a preliminary assessment Am J Manag Care 16 2010 65 69
14. A.S. Levey, J. Coresh, E. Balk, A.T. Kausz, A. Levin, M.W. Steffes, R.J. Hogg, R.D. Perrone, J. Lau, G. Eknoyan National Kidney Foundation National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification Ann Intern Med 139 2003 137 147
15. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification Am J Kidney Dis 39 2002 S46 75
16. H. Quan, V. Sundararajan, P. Halfon, A. Fong, B. Burnand, J.C. Luthi, L.D. Saunders, C.A. Beck, T.E. Feasby, and W.A. Ghali Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data Med Care 43 2005 1130 1139
17. C.A. Naughton Drug-induced nephrotoxicity Am Fam Physician 78 2008 743 750
18. N. Pannu, and M.K. Nadim An overview of drug-induced acute kidney injury Crit Care Med 36 2008 S216 223
19. S.D. Navaneethan, F. Pansini, V. Perkovic, C. Manno, F. Pellegrini, D.W. Johnson, J.C. Craig, and G.F. Strippoli HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis Cochrane Database Syst Rev 2 2009 CD007784
20. J.M. Bland, and D.G. Altman Regression towards the mean BMJ 308 1994 1499
21. J.M. Bland, and D.G. Altman Some examples of regression towards the mean BMJ 309 1994 780
22. C.L. Lai, W.Y. Shau, C.H. Chang, M.F. Chen, and M.S. Lai Statin use and cataract surgery: a Nationwide retrospective cohort study in elderly ethnic Chinese patients Drug Saf 36 2013 1017 1024